Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-124 and Parkinson’s disease: A biomarker with therapeutic potential
Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi
Pharmacological Research (2019) Vol. 150, pp. 104515-104515
Closed Access | Times Cited: 112

Showing 26-50 of 112 citing articles:

Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration
Reiner Kunze, Silvia Fischer, Hugo H. Marti, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 15
Parkinson’s Disease and MicroRNAs: A Duel Between Inhibition and Stimulation of Apoptosis in Neuronal Cells
Mohamed J. Saadh, Ahmed Faisal, Mohaned Adil, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 8552-8574
Closed Access | Times Cited: 5
Values of epigenetic markers in Parkinson's disease as biomarkers and therapeutic targets: A narrative review
Dhruv Parikh, Manan Shah
NeuroMarkers. (2025), pp. 100037-100037
Open Access
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
(2025)
Open Access
Epigenetic regulation of iron metabolism and ferroptosis in Parkinson’s disease: Identifying novel epigenetic targets
Xiaodie Gao, Jun Ding, Junxia Xie, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Advances in Research on Exosomal miRNAs in Central Nervous System Diseases
Guangli Feng, Xiaoqian Lan, Shiyi Qin, et al.
ASN NEURO (2025) Vol. 17, Iss. 1
Open Access
microRNAs as molecular tools for brain health: Neuroprotective potential in neurodegenerative disorders
Mozhgan Abasi, Anvarsadat Kianmehr, Atena Variji, et al.
Neuroscience (2025)
Closed Access
Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer’s Disease
Mohamed J. Saadh, Faris Anad Muhammad, Tuqa S. Alazzawi, et al.
Molecular Neurobiology (2025)
Closed Access
Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
Efthalia Angelopoulou, Yam Nath Paudel, Chiara Villa, et al.
Biology (2020) Vol. 9, Iss. 4, pp. 86-86
Open Access | Times Cited: 32
Acteoside exerts neuroprotection effects in the model of Parkinson's disease via inducing autophagy: Network pharmacology and experimental study
Mutalifu Aimaiti, Ainiwaer Wumaier, Yiliyasi Aisa, et al.
European Journal of Pharmacology (2021) Vol. 903, pp. 174136-174136
Closed Access | Times Cited: 31
Nanomaterials as novel agents for amelioration of Parkinson’s disease
Junguang Wu, Xuejing Cui, Pu Chun Ke, et al.
Nano Today (2021) Vol. 41, pp. 101328-101328
Closed Access | Times Cited: 27
Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease
Kamatham Pushpa Tryphena, Urati Anuradha, Rohith Kumar, et al.
Journal of Alzheimer s Disease (2022) Vol. 94, Iss. s1, pp. S187-S202
Open Access | Times Cited: 20
Molecular Mechanisms Involved in the Regulation of Neurodevelopment by miR-124
Xi Gu, Xiaona Xu, Chunhong Jia, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 7, pp. 3569-3583
Closed Access | Times Cited: 11
Pivotal Role of Fyn Kinase in Parkinson’s Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?
Efthalia Angelopoulou, Yam Nath Paudel, Thomas Julian, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 4, pp. 1372-1391
Closed Access | Times Cited: 30
Silencing of miR‐497‐5p inhibits cell apoptosis and promotes autophagy in Parkinson's disease by upregulation of FGF2
Wenjie Zhu, Hui Zhang, Jun Gao, et al.
Environmental Toxicology (2021) Vol. 36, Iss. 11, pp. 2302-2312
Closed Access | Times Cited: 26
The potential role of miR-124-3p in tumorigenesis and other related diseases
Qian Li, Shuqing Liu, Jinsong Yan, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 4, pp. 3579-3591
Closed Access | Times Cited: 25
Multifaceted Regulation of MicroRNA Biogenesis: Essential Roles and Functional Integration in Neuronal and Glial Development
Izabela Suster, Yue Feng
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6765-6765
Open Access | Times Cited: 24
MicroRNA-124 attenuates PTSD-like behaviors and reduces the level of inflammatory cytokines by downregulating the expression of TRAF6 in the hippocampus of rats following single-prolonged stress
Yao Chen, Qi An, Shuting Yang, et al.
Experimental Neurology (2022) Vol. 356, pp. 114154-114154
Open Access | Times Cited: 16
Enhancing Neuroprotection in Mouse Model of Parkinson’s Disease through Protein Nanosystem Conjugation with ApoE Peptide for miR-124 Delivery
Juan Zhang, Bozhou Cui, Ting He, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 7, pp. 8199-8212
Closed Access | Times Cited: 3
Regulatory mechanism of miR‐20a‐5p in neuronal damage and inflammation in lipopolysaccharide‐induced BV2 cells and MPTP‐HCl‐induced Parkinson's disease mice
Yanlei Gao, Dan Sheng, Wei-Guang Chen
Psychogeriatrics (2024) Vol. 24, Iss. 4, pp. 752-764
Closed Access | Times Cited: 3
Apilarnil exerts neuroprotective effects and alleviates motor dysfunction by rebalancing M1/M2 microglia polarization, regulating miR-155 and miR-124 expression in a rotenone-induced Parkinson’s disease rat model
Rania M. Salama, Samar F. Darwish, Rana Yehia, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112536-112536
Closed Access | Times Cited: 3
Spermidine as an epigenetic regulator of autophagy in neurodegenerative disorders
Sairaj Satarker, Joel Wilson, Kiran Kumar Kolathur, et al.
European Journal of Pharmacology (2024) Vol. 979, pp. 176823-176823
Open Access | Times Cited: 3
miR-124 coordinates metabolic regulators acting at early stages of human neurogenesis
Geurim Son, Yongwoo Na, Yongsung Kim, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson’s disease
Zachary Gaertner, Cameron Oram, Amanda Schneeweis, et al.
(2024)
Open Access | Times Cited: 3
MicroRNA‐124‐3p attenuates the development of nerve injury–induced neuropathic pain by targeting early growth response 1 in the dorsal root ganglia and spinal dorsal horn
Mingjun Jiang, Xuan Zhang, Xueli Wang, et al.
Journal of Neurochemistry (2021) Vol. 158, Iss. 4, pp. 928-942
Open Access | Times Cited: 20

Scroll to top